United States · Bill · S
S. 251 (107th)
RU-486 Patient Health and Safety Protection Act
Introduced
6 February 2001
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
—
Subjects
Discovery layer
Source updated
19 August 2025
Summary
RU-486 Patient Health and Safety Protection Act - Restricts the prescribing of the drug mifepristone (commonly referred to as RU-486, to be marketed as Mifeprex) to physicians who meet specified requirements.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 6 February 2001
Introduced in Senate (PDF)
Introduced in Senate · EN · 6 February 2001
Introduced in Senate
summary · EN · 6 February 2001
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/107th-congress/senate-bill/251
- Open data entity: https://api.congress.gov/v3/bill/107/s/251